What does CA stand for?

Product Information Product Name NANOPIA(R) KL-6 Eisai Assay System Automated Clinical Chemistry Analyser Reagents KL-6 buffer solution KL-6 latex test solution Package 24mL x 2 8mL x 2 List Price 136,000 JPY 204,000 JPY Intended Use Determination of sialylated carbohydrate antigen (KL-6) level in serum or plasma Manufactured by Sekisui Medical Co.

The book explores advances in carbohydrate-based vaccines, in terms of the handling of carbohydrate antigens by the immune system, the regulatory issues related to vaccine accreditation, and the compilation of chemical processes that have been developed in glycoconjugation chemistry.

However, they also reported prognostic factors that clearly showed the differences in patients without any risk factor [more than two metastases, large metastases >10 cm, elevated carbohydrate antigen (CA) 19-9 and rectal primary; calculated 5-year survival, 59%] compared to those with unfavourable factors (more than two risk factors; calculated 5-year survival, [less than or equal to] 1%) [13].

Additional serologic testing revealed that the patient's alpha-fetoprotein (AFP), human placental alkaline phosphatase, prostate-specific antigen, carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), and thyroglobulin levels were within normal limits.

Biomira has also received a Notice of Allowance from the United States Patent and Trademark Office for its patent application entitled "Process For Preparation of Glycosides of Tumor-Associated Carbohydrate Antigens.

This novel vaccine platform enables presentation of multiple carbohydrate antigens on a single synthetic scaffold and has been shown to trigger an in vivo immune response to multiple oncology related targets.

Serum carbohydrate antigen (CA) 19-9 is considered to be the most sensitive/specific marker for pancreatic cancer, although it has also been associated with biliary, hepatocellular, gastric, colonic and nongastrointestinal malignancies.

There are caveats to these general rules, in that a protective titer prior to immuniz ation may not result in a significant rise in antibody level postimmunization, particularly following immunization with carbohydrate antigens.